Virtus ETF Advisers’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $356K | Buy |
|
|||||
|
2024
Q3 | $544K | Hold |
|
|||||
|
2024
Q2 | $310K | Buy |
|
|||||
|
2024
Q1 | $103K | Sell |
|
|||||
|
2023
Q4 | $94.7K | Buy |
|
|||||
|
2023
Q3 | $80.3K | Sell |
|
|||||
|
2023
Q2 | $122K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $187K | Buy |
|
|||||
|
2022
Q2 | $141K | Buy |
|
|||||
|
2022
Q1 | $117K | Sell |
|
|||||
|
2021
Q4 | $179K | Buy |
|
|||||
|
2021
Q3 | $197K | Sell |
|
|||||
|
2021
Q2 | $219K | Sell |
|
|||||
|
2021
Q1 | $254K | Buy |
|
|||||
|
2020
Q4 | $220K | Buy |
|
|||||
|
2020
Q3 | $229K | Sell |
|
|||||
|
2020
Q2 | $233K | Buy |
|